• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Predictive Diagnostics - Global Strategic Business Report Product Image

Predictive Diagnostics - Global Strategic Business Report

  • ID: 2692229
  • September 2013
  • Region: Global
  • 148 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Predictive Diagnostics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 58 companies including many key and niche players such as:

- Abbott Molecular
- Almac Group Ltd.
- BioGenex
- Covance, Inc.
- Dako Denmark A/S
- Epistem Plc
- F. Hoffmann-La Roche Ltd.
- Genomic Health, Inc.
- MDxHEALTH, Inc.
- Myriad Genetics, Inc.
- Precision Therapeutics, Inc.
- Prometheus Laboratories
- QIAGEN N.V.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. Executive Summary

1. INDUSTRY OVERVIEW
Curtain Raiser
Outlook for Predictive Diagnostics Market

2. MAJOR MARKET TRENDS, DRIVERS & ISSUES
Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
Diagnosed Cases of Cancer on the Rise
Table 1: Global Cancer Incidence by Region: 2012 (includes corresponding Graph/Chart)
Table 2: Cancer Incidence in Developed Nations By Site: 2012 (includes corresponding Graph/Chart)
Incidence of Neurodegenerative Diseases Increasing
Alzheimer's Disease
Huntington's Disease
Quick Facts on the Global Prevalence of Huntingtons Disease
Ballooning Global Population Offers Significant Growth Opportunities
Table 3: Top 25 Countries Worldwide in Terms of Population: 2007, 2010 & 2013
Ageing Population Boosts Predictive Diagnostics
Table 4: Elderly Population (65+ Years) as a Percentage of the Total Population: 2000 & 2025 (includes corresponding Graph/Chart)
Table 5: Life Expectancy at Birth for Select Countries (2012) (includes corresponding Graph/Chart)
Table 6: Percentage of Population Aged 65 and Above in EU
Countries, the US and Japan (1960-2030) (includes corresponding Graph/Chart)
Pharmacogenomics Development Augurs Growth of Predictive Diagnostics
Discovery of Novel Biomarkers Crucial to Predictive Diagnostics
Next-Generation Sequencing - A Giant Leap in Genome Sequencing
Breast Cancer Gene Testing Market to Expansion Strongly
Myriad Genetics - The Unquestioned Leader in Breast Cancer Testing
Growing Direct-to-Consumer Genetic Testing: Boon or Bane??
Genomic Research Remains Confined to Fundamental Research
Unresolved Issues Hamper Widespread Implementation of Genetic Diagnosis and Testing for Monogenetic Disease
Dearth of Genetic Counselors a Major Hurdle for the Predictive Genetic Testing
Framework for Validation, Regulation and Ethical Issues - The Need of the Hour

3. PRODUCT OVERVIEW
Introduction
Underlying Principles of Predictive Diagnostics
Predictive Diagnostics vs. Conventional Testing
Characteristics of an Effective Predictive Diagnostic Test
Applications of Predictive Diagnostics
Pre-Symptomatic
Predisposition Testing
Cancer Testing
Carrier Identification
Pharmacogenetics
Pharmacogenomics
Prenatal Diagnosis
Steps in Genetic Testing Process
Limitations
Risks and Other Limitations of Genetic Testing
Select Diseases Identified Using Predictive Diagnostics
Cystic Fibrosis
Breast and Ovarian Cancer (BRCA)
Alzheimers Disease
Colorectal Cancer
Hemochromatosis (HH)
Huntingtons Disease (HD)
Costs of Select Tests
Table 7: Costs of Select Genetic Tests
Medical Ethics Surrounding Predictive Diagnostics

4. RECENT INDUSTRY ACTIVITY
QIAGEN Takes Over Ingenuity Systems
Cenix to Partner with Debiopharm
MolecularMD Corp. Obtains License for LKB1 Gene Technology
MolecularMD Develops and Validates Assay Tests to Determine LKB1 Expression and Mutation Status
Abbotts Galectin-3 Assay Awarded CE Marking
Asuragen Introduces BRAF and KRAS Mutation Testing Services
Dako to Acquire IP rights from System Dynamic
Agilent Acquires Dako
Celgene Takes Over Avila Therapeutics
Signal Genetics to Acquire ChipDX
Roche and Med Fusion Form Strategic Alliance
Epistem Inks Supply and Distribution Agreement with Becton Dickinson for Tuberculosis Test
Rosetta Genomics Signs Co-Marketing Agreement with Precision Therapeutics
Quintiles Establishes Oxford Cancer Biomarkers for Personalized Medicine Care
Cornell University Licenses microRNA Diagnostic IP to Prolias Technologies
Signal Genetics Introduces ResultsPX™ Analysis Tool and Physician Web Portal for Genetic Test Results
Myriad Genetics Acquires Rules-Based Medicine
Nestlé Health Science Acquires Prometheus
NeoGenomics Signs Distribution Agreement with Signal Genetics
MDxHealth Signs Collaboration Agreement with Newcastle University, Pfizer and CRT
Roche Forms Strategic Partnership with Cedars-Sinai
Quanticel, Celgene, and Versant Sign Strategic Collaboration Agreement for Cancer Drug Discovery
Epistem Collaborates with NPIA for ADAPT Program
Epistem and Xcelris Sign TB Diagnostic Collaboration
Ventana Medical Systems Obtains FDA Approval for Commercialization of HER2 Dual ISH Assay
Roche's Cobas KRAS Mutation Test Receives CE Mark
Prometheus Introduces PROMETHEUS IBD sgi Diagnostic Test
Signal Genetics and UAMS Sign Licensing Deal
Predictive Biosciences Acquires OncoDiagnostic Laboratory
Golden Helix Collaborates with Sirius Genomics
Signal Genetics Partners with Array BioPharma
MDxHealth and Predictive Biosciences Sign Licensing Agreement
Prometheus Signs Collaboration Agreement with Tarrot Laboratories
Roche Secures Associate License for P13K Biomarker from QIAGEN
Myriad Genetics Rolls Out PANEXIA

5. FOCUS ON SELECT PLAYERS
Abbott Molecular (US)
Almac Group Ltd. (Ireland)
BioGenex (US)
Covance, Inc. (US)
Dako Denmark A/S (Denmark)
Epistem Plc (UK)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genomic Health, Inc. (US)
MDxHEALTH, Inc. (US)
Myriad Genetics, Inc. (US)
Precision Therapeutics, Inc. (US)
Prometheus Laboratories (US)
QIAGEN N.V. (Netherlands)

6. GLOBAL MARKET PERSPECTIVE
Table 8: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 9: World Historic Review for Predictive Diagnostics by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 10: World 15-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, and Rest of World Markets for the Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Outlook
Genetic Information Nondiscrimination Act Boosts Genetic Testing
Direct-to-Consumer Testing - A Growing Market
Transparency
Provider Education
Test and Laboratory Quality
High Frequency of Predictive CFTR Screening in Expectant Mothers
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 11: US Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 12: US Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 13: Canadian Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 14: Canadian Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 15: Japanese Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 16: Japanese Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current and Future Analysis
Predictive Testing to Dominate Genetic Testing and Screening Services in Europe
Hassles Faced by European Genetic Testing Market
Strategic Corporate Developments
B.Market Analytics
Table 17: European Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 18: European Historic Review for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 19: European 15-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 20: French Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 21: French Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current and Future Analysis
German Ethics Council Releases Recommendations for Genetic Testing
Proposals Mentioned: A Snapshot
Strategic Corporate Development
Imgm Laboratories Gmbh - A Key Player
B.Market Analytics
Table 22: German Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 23: German Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 24: Italian Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 25: Italian Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current and Future Analysis
UK Government Encourages Genetic Testing
Strategic Corporate Developments
Epistem Plc - A Key Player
B.Market Analytics
Table 26: UK Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 27: UK Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)
4e. REST OF EUROPE
A.Market Analysis
Current and Future Analysis
Strategic Corporate Development
Key Players
B.Market Analytics
Table 28: Rest of Europe Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 29: Rest of Europe Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

5. REST OF WORLD
A.Market Analysis
Current and Future Analysis
Strategic Corporate Developments
Emsurg Healthcare (India) Pvt. Limited - A Key Player
B.Market Analytics
Table 30: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 31: Rest of World Historic Review for Predictive Diagnostics with Annual Revenue Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 58 (including Divisions/Subsidiaries - 61)
The United States (31)
Canada (2)
Europe (19)
- Germany (4)
- The United Kingdom (7)
- Spain (1)
- Rest of Europe (7)
Asia-Pacific (Excluding Japan) (7)
Middle East (2)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos